Download
1 / 12
120 likes | 238 Views
This document outlines the expert input instructions for evaluating the NQF Safe Practices Consensus Report published in May 2003. Participants are directed to provide their expert interpretations and responses in the designated table format across specified slides. Key practices include ensuring pharmacist participation in medication processes and standardized use of abbreviations in prescriptions. Participants are encouraged to return the completed forms to the designated lead contact and include any further comments as required.
E N D
NQF Safe Practices Consensus Evaluation October 2003 Texas Medical Institute of Technology • Subject Matter Expert Input Instructions: • PROVIDE INFORMATION REQUESTED IN TABLE PROVIDED: • Fill in the sections of the table on slide # 2 with your expert interpretation and answers to the questions in the shaded area. • Slide #4 was provided for overflow information that may not all fit on slide # 2. • USE SLIDE # 3 AS YOUR NQF REFERENCE RESOURCE : • The content has been taken directly from the NQF Safe Practices Consensus Report published May 2003. • PLEASE RETURN THE FORMS BY E-MAIL TO THE LEAD PERSON DEFINED IN THE BOX ABOVE. • IF YOU HAVE ANY ADDITIONAL COMMENTS, PLEASE RECORD THEM IN THE BOX TO THE RIGHT. • IF YOU HAVE ANY QUESTIONS, PLEASE CALL OR E-MAIL THE LEAD OR ASSIST PERSONS FOR THE PRACTICE DESIGNATED ABOVE. • THE LEAD PERSON IS RESPONSIBLE TO COLLECT THE INFORMATION YOU SUBMIT AND THE ASSIST PERSON IS AVAILABLE TO ASSIST YOU AND THE LEAD PERSON. Subject Matter Expert Personal Comments: • ___________________________ • ___________________________
NQF Safe Practice #5: Pharmacists should actively participate in the medication-use process. Fill in the table below. Use slide #4 for overflow information.
NQF Safe Practice #5: Pharmacists should actively participate in the medication-use process. Leapfrog Deliverables
NQF Safe Practice #5: Pharmacists should actively participate in the medication-use process.
NQF Safe Practices Consensus Evaluation October 2003 Texas Medical Institute of Technology • Subject Matter Expert Input Instructions: • PROVIDE INFORMATION REQUESTED IN TABLE PROVIDED: • Fill in the sections of the table on slide # 2 with your expert interpretation and answers to the questions in the shaded area. • Slide #4 was provided for overflow information that may not all fit on slide # 2. • USE SLIDE # 3 AS YOUR NQF REFERENCE RESOURCE : • The content has been taken directly from the NQF Safe Practices Consensus Report published May 2003. • PLEASE RETURN THE FORMS BY E-MAIL TO THE LEAD PERSON DEFINED IN THE BOX ABOVE. • IF YOU HAVE ANY ADDITIONAL COMMENTS, PLEASE RECORD THEM IN THE BOX TO THE RIGHT. • IF YOU HAVE ANY QUESTIONS, PLEASE CALL OR E-MAIL THE LEAD OR ASSIST PERSONS FOR THE PRACTICE DESIGNATED ABOVE. • THE LEAD PERSON IS RESPONSIBLE TO COLLECT THE INFORMATION YOU SUBMIT AND THE ASSIST PERSON IS AVAILABLE TO ASSIST YOU AND THE LEAD PERSON. Subject Matter Expert Personal Comments: • ___________________________ • ___________________________
NQF Safe Practice #6: Verbal orders should be recorded whenever possible and immediately read back to the prescriber. Fill in the table below. Use slide #4 for overflow information.
NQF Safe Practice #6: Verbal orders should be recorded whenever possible and immediately read back to the prescriber. Leapfrog Deliverables
NQF Safe Practice #6: Verbal orders should be recorded whenever possible and immediately read back to the prescriber.
NQF Safe Practices Consensus Evaluation October 2003 Texas Medical Institute of Technology • Subject Matter Expert Input Instructions: • PROVIDE INFORMATION REQUESTED IN TABLE PROVIDED: • Fill in the sections of the table on slide # 2 with your expert interpretation and answers to the questions in the shaded area. • Slide #4 was provided for overflow information that may not all fit on slide # 2. • USE SLIDE # 3 AS YOUR NQF REFERENCE RESOURCE : • The content has been taken directly from the NQF Safe Practices Consensus Report published May 2003. • PLEASE RETURN THE FORMS BY E-MAIL TO THE LEAD PERSON DEFINED IN THE BOX ABOVE. • IF YOU HAVE ANY ADDITIONAL COMMENTS, PLEASE RECORD THEM IN THE BOX TO THE RIGHT. • IF YOU HAVE ANY QUESTIONS, PLEASE CALL OR E-MAIL THE LEAD OR ASSIST PERSONS FOR THE PRACTICE DESIGNATED ABOVE. • THE LEAD PERSON IS RESPONSIBLE TO COLLECT THE INFORMATION YOU SUBMIT AND THE ASSIST PERSON IS AVAILABLE TO ASSIST YOU AND THE LEAD PERSON. Subject Matter Expert Personal Comments: • ___________________________ • ___________________________
NQF Safe Practice #7: Use only standardized abbreviations and dose designations. Fill in the table below. Use slide #4 for overflow information.
NQF Safe Practice #7: Use only standardized abbreviations and dose designations. Leapfrog Deliverables
NQF Safe Practice #7: Use only standardized abbreviations and dose designations.
